[
  {
    "ts": null,
    "headline": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "summary": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=93e37b6a992fa848b91ee0e96ba2f47786a4cb632c7f1bcdcf48bdf96cc4600f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745427960,
      "headline": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "id": 134085986,
      "image": "",
      "related": "LH",
      "source": "MarketWatch",
      "summary": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=93e37b6a992fa848b91ee0e96ba2f47786a4cb632c7f1bcdcf48bdf96cc4600f"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72",
    "summary": "The board of Labcorp Holdings Inc. ( NYSE:LH ) has announced that it will pay a dividend of $0.72 per share on the 11th...",
    "url": "https://finnhub.io/api/news?id=02c1afa69298196101dffcc75217fb3c6a4033d3bb19a546315d0a2dd69cf07f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745414329,
      "headline": "Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72",
      "id": 134047066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "The board of Labcorp Holdings Inc. ( NYSE:LH ) has announced that it will pay a dividend of $0.72 per share on the 11th...",
      "url": "https://finnhub.io/api/news?id=02c1afa69298196101dffcc75217fb3c6a4033d3bb19a546315d0a2dd69cf07f"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio with two solutions: Labcorp Plasma Detect for clinical use to help assess the risk of disease recurrence in stage III colon cancer patients, and the availability of PGDx elio plasma focus Dx, the first and only kitted, pan-solid tumor liquid biopsy test authorized by the U.S. Food and Drug Administration (FDA) to identify patients who may bene",
    "url": "https://finnhub.io/api/news?id=d8b800b0a5be5eb4af1cd3a17be027e0e3e5cd4ac8922bd6dda7388626444eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745406000,
      "headline": "Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions",
      "id": 134047067,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio with two solutions: Labcorp Plasma Detect for clinical use to help assess the risk of disease recurrence in stage III colon cancer patients, and the availability of PGDx elio plasma focus Dx, the first and only kitted, pan-solid tumor liquid biopsy test authorized by the U.S. Food and Drug Administration (FDA) to identify patients who may bene",
      "url": "https://finnhub.io/api/news?id=d8b800b0a5be5eb4af1cd3a17be027e0e3e5cd4ac8922bd6dda7388626444eda"
    }
  }
]